Literature DB >> 25579522

The usefulness of diffusion-weighted magnetic resonance imaging in bladder cancer staging and functional analysis.

Yasushi Yamada1, Shigeki Kobayashi, Shiho Isoshima, Kiminobu Arima, Hajime Sakuma, Yoshiki Sugimura.   

Abstract

AIM: We assessed the effect of adding diffusion-weighted magnetic resonance imaging (DW-MRI) to conventional MRI for T staging and the correlation between apparent diffusion coefficient (ADC) values and clinicopathological parameters for patients with bladder cancer.
MATERIALS AND METHODS: We retrospectively reviewed the records of 160 patients with bladder cancer who underwent MRI at our institute. All patients were routinely assessed with conventional MR imaging. Since January 2008, we added DW-MRI.
RESULTS: In these 160 patients, 127 (79.4%) tumors were detectable by MRI. In all patients with detectable tumors, on a stage-by-stage basis, 96 (75.6%) of 127 patients received the correct diagnosis. With DW-MRI, accurate diagnosis was obtained in 80 (80.0%) of 100 cases; without DWI in only 16 (59.3%) of 27 cases (P=0.026). For T staging, the accuracy for distinguishing muscle invasion (T≦1 vs T≧2) with DW-MRI (83.0%) was superior to that without DW-MRI (66.7%). The accuracy for distinguishing perivesical fat invasion (T≦2 vs T≧3) with DW-MRI (98.0%) was also superior to that without DW-MRI (92.6%). The ADC values were significantly related with tumor diameter (<3 cm vs ≧3 cm, P<0.001), histopathological grade (low grade vs high grade, P<0.001), T stage (≦T1 vs ≧T2, P<0.001), and operative method (transurethral resection vs total cystectomy, P<0.001).
CONCLUSIONS: We demonstrated that DW-MRI is not only useful for bladder cancer T staging, but also a prognostic factor for patients with bladder cancer.

Entities:  

Mesh:

Year:  2014        PMID: 25579522     DOI: 10.4103/0973-1482.138225

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  6 in total

1.  Comparison of the diagnostic accuracy and validity of biparametric MRI and multiparametric MRI-based VI-RADS scoring in bladder cancer; is contrast material really necessary in detecting muscle invasion?

Authors:  Serdar Aslan; Ismet Mirac Cakir; Ural Oguz; Tumay Bekci; Erhan Demirelli
Journal:  Abdom Radiol (NY)       Date:  2021-12-17

2.  Assessment of colon and bladder crosstalk in an experimental colitis model using contrast-enhanced magnetic resonance imaging.

Authors:  R A Towner; N Smith; D Saunders; S B Van Gordon; K R Tyler; A B Wisniewski; B Greenwood-Van Meerveld; R E Hurst
Journal:  Neurogastroenterol Motil       Date:  2015-08-24       Impact factor: 3.598

3.  Diffusion weighted magnetic resonance imaging in bladder cancer, is it time to replace biopsy?

Authors:  Rima S Al Johi; Gehan S Seifeldein; Ahmed M Moeen; Noha A Aboulhagag; Ehab M Moussa; Diaa A Hameed; Hisham M Imam
Journal:  Cent European J Urol       Date:  2017-01-16

4.  A glance at imaging bladder cancer.

Authors:  Ebru Salmanoglu; Ethan Halpern; Edouard J Trabulsi; Sung Kim; Mathew L Thakur
Journal:  Clin Transl Imaging       Date:  2018-05-16

5.  Pure Lymphoepithelioma-Like Carcinoma Originating from the Urinary Bladder.

Authors:  Takashi Nagai; Taku Naiki; Noriyasu Kawai; Keitaro Iida; Toshiki Etani; Ryosuke Ando; Shuzo Hamamoto; Yosuke Sugiyama; Atsushi Okada; Kentaro Mizuno; Yukihiro Umemoto; Takahiro Yasui
Journal:  Case Rep Oncol       Date:  2016-03-23

6.  Bladder cancer: detection and image quality compared among iShim, RESOLVE, and ss-EPI diffusion-weighted MR imaging with high b value at 3.0 T MRI.

Authors:  Hongyi Li; Lin Liu; Qinglei Shi; Alto Stemmer; Hong Zeng; Yi Li; Mengchao Zhang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.